Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells

Chen, Yen Shun, Pelekanos, Rebecca A., Ellis, Rebecca L., Horne, Rachel, Wolvetang, Ernst J. and Fisk, Nicholas M. (2012) Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Translational Medicine, 1 2: 83-95. doi:10.5966/sctm.2011-0022

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads

Author Chen, Yen Shun
Pelekanos, Rebecca A.
Ellis, Rebecca L.
Horne, Rachel
Wolvetang, Ernst J.
Fisk, Nicholas M.
Title Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells
Journal name Stem Cells Translational Medicine   Check publisher's open access policy
ISSN 2157-6564
Publication date 2012-02
Sub-type Article (original research)
DOI 10.5966/sctm.2011-0022
Volume 1
Issue 2
Start page 83
End page 95
Total pages 13
Place of publication Durham, NC, United States
Publisher AlphaMed Press
Collection year 2013
Language eng
Formatted abstract
The translational potential of mesenchymal stem/stromal cells (MSCs) is limited by their rarity in somatic organs, heterogeneity, and need for harvest by invasive procedures. Induced pluripotent stem cells (iPSCs) could be an advantageous source of MSCs, but attempts to derive MSCs from pluripotent cells have required cumbersome or untranslatable techniques, such as coculture, physical manipulation, sorting, or viral transduction. We devised a single-step method to direct mesengenic differentiation of human embryonic stem cells (ESCs) and iPSCs using a small molecule inhibitor. First, epithelial-like monolayer cells were generated by culturing ESCs/iPSCs in serum-free medium containing the transforming growth factor-β pathway inhibitor SB431542. After 10 days, iPSCs showed upregulation of mesodermal genes (MSX2, NCAM, HOXA2) and downregulation of pluripotency genes (OCT4, LEFTY1/2). Differentiation was then completed by transferring cells into conventional MSC medium. The resultant development of MSC-like morphology was associated with increased expression of genes, reflecting epithelial-to-mesenchymal transition. Both ESC- and iPSC-derived MSCs exhibited a typical MSC immunophenotype, expressed high levels of vimentin and N-cadherin, and lacked expression of pluripotency markers at the protein level. Robust osteogenic and chondrogenic differentiation was induced in vitro in ES-MSCs and iPS-MSCs, whereas adipogenic differentiation was limited, as reported for primitive fetal MSCs and ES-MSCs derived by other methods. We conclude that treatment with SB431542 in two-dimensional cultures followed by culture-induced epithelial-to-mesenchymal transition leads to rapid and uniform MSC conversion of human pluripotent cells without the need for embryoid body formation or feeder cell coculture, providing a robust, clinically applicable, and efficient system for generating MSCs from human iPSCs.
Keyword Mesenchymal stem cells
Pluripotent stem cells
Induced pluripotent stem cells
Embryonic stem cells
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 50 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 55 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 20 Jan 2013, 00:39:54 EST by System User on behalf of UQ Centre for Clinical Research